NEWS

By JMa000295 December 4, 2024
ReBlood Actively Expands into Southeast Asian Markets, Deepening International Cooperation to Support Listing on U.S. Capital Markets
By JMa000295 November 15, 2024
ReBlood invests millions in Yushan AI for automated labs and smart consulting, enhancing privacy and boosting AI healthcare integration.
By JMa000295 December 4, 2024
ReBlood Actively Expands into Southeast Asian Markets, Deepening International Cooperation to Support Listing on U.S. Capital Markets
By JMa000295 November 15, 2024
ReBlood invests millions in Yushan AI for automated labs and smart consulting, enhancing privacy and boosting AI healthcare integration.
Share by: